» Articles » PMID: 19192444

Gender Differences in Generalized Anxiety Disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

Overview
Specialty Psychiatry
Date 2009 Feb 5
PMID 19192444
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess gender differences in the epidemiology, comorbidity, and treatment-seeking patterns of DSM-IV generalized anxiety disorder (GAD) in the United States.

Method: Data were derived from the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions, a large cross-sectional survey of a representative sample (N = 43,093) of the U.S. population.

Results: The lifetime and 12-month male:female prevalence ratios of DSM-IV GAD were 1:1.9 and 1:2.2, respectively. Men with GAD had significantly higher rates of comorbid alcohol and drug use disorders, nicotine dependence, and antisocial personality disorder. Women with GAD had significantly higher rates of comorbid mood disorders (except bipolar disorder) and anxiety disorders (except social anxiety disorder). Men with GAD reported greater use of alcohol and drugs to help relieve GAD symptoms. GAD in women was associated with higher rates of family history of depression. Disability associated with GAD was greater in women than in men. Rates of treatment seeking for DSM-IV GAD were low for both genders, but particularly low among men.

Conclusion: There are significant gender differences in the prevalence, comorbidity pattern, sociodemographic and clinical correlates, course, and treatment-seeking rates of persons with DSM-IV GAD. Increased recognition and treatment of GAD, particularly among men, could lead to substantial reductions in the societal and personal burden and improve the quality of life of those afflicted with this disorder.

Citing Articles

Maternal Social Phobia, but not Generalized Anxiety, Symptoms Interact with Early Childhood Error-Related Negativity to Prospectively Predict Child Anxiety Symptoms.

Nyman-Mallis T, Heffer R, Brooker R Res Child Adolesc Psychopathol. 2025; .

PMID: 39760790 DOI: 10.1007/s10802-024-01284-9.


A digital phenotyping dataset for impending panic symptoms: a prospective longitudinal study.

Jang S, Sun T, Shin S, Lee H, Shin Y, Yeom J Sci Data. 2024; 11(1):1264.

PMID: 39572578 PMC: 11582692. DOI: 10.1038/s41597-024-04147-6.


Arabic translation and validation of the clinician administered Staden schizophrenia anxiety rating scale (S-SARS).

Fekih-Romdhane F, Al Mouzakzak F, Abilmona G, Moustafa A, Dahdouh O, Hallit S Heliyon. 2024; 10(21):e39792.

PMID: 39553570 PMC: 11564944. DOI: 10.1016/j.heliyon.2024.e39792.


Comorbidity and sex differences in functional disorders and internalizing disorders.

Thomas N, Gillespie N, Kendler K, Oldehinkel A, Rosmalen J, van Loo H Gen Hosp Psychiatry. 2024; 90:91-98.

PMID: 39079424 PMC: 11390307. DOI: 10.1016/j.genhosppsych.2024.07.013.


Blunted stimulus-preceding negativity during reward anticipation in major depressive disorder.

Ren X, White E, Nacke M, Mayeli A, Touthang J, Al Zoubi O J Affect Disord. 2024; 362:779-787.

PMID: 39029684 PMC: 11316661. DOI: 10.1016/j.jad.2024.07.060.


References
1.
Rubio G, Lopez-Ibor J . Generalized anxiety disorder: a 40-year follow-up study. Acta Psychiatr Scand. 2007; 115(5):372-9. DOI: 10.1111/j.1600-0447.2006.00896.x. View

2.
Frostholm L, Oernboel E, Christensen K, Toft T, Olesen F, Weinman J . Do illness perceptions predict health outcomes in primary care patients? A 2-year follow-up study. J Psychosom Res. 2007; 62(2):129-38. DOI: 10.1016/j.jpsychores.2006.09.003. View

3.
Leaf P, Bruce M, Tischler G, Holzer 3rd C . The relationship between demographic factors and attitudes toward mental health services. J Community Psychol. 1987; 15(2):275-84. DOI: 10.1002/1520-6629(198704)15:2<275::aid-jcop2290150216>3.0.co;2-j. View

4.
Altemus M . Sex differences in depression and anxiety disorders: potential biological determinants. Horm Behav. 2006; 50(4):534-8. DOI: 10.1016/j.yhbeh.2006.06.031. View

5.
Kroenke K, Spitzer R . Gender differences in the reporting of physical and somatoform symptoms. Psychosom Med. 1998; 60(2):150-5. DOI: 10.1097/00006842-199803000-00006. View